Financial Reports 2018

This Stream includes all of our Financial Reports 2018 Flipbooks

  • Annual Report 2018

    Annual Report 2018

    2018 was once again a year filled with strong scientific and clinical program development achievements for Prometic.

    Read PDF
  • Quarterly Report 2018 Q3

    Quarterly Report 2018 Q3

    Successful Type C meeting with FDA: agreement on proposed plan of action for RyplazimTM (plasminogen) manufacturing process along with Substantial reduction in R&D costs of up to $30 million.

    Read PDF
  • Quarterly Report Q2 2018

    Quarterly Report Q2 2018

    Advanced multiple initiatives aimed at extending cash runway, including ongoing partnering discussions related to both PBI-4050 and RyplazimTM (plasminogen).

    Read PDF
  • Quarterly Report Q1 2018

    Quarterly Report Q1 2018

    Prometic reports its 2018 first quarter highlights and financial results

    Read PDF
  • Interested in Investment Opportunities?

    Contact Us
  • Notice of Annual and Special Meeting of Shareholders and Management Information Circular March 22, 2018

    Notice of Annual and Special Meeting of Shareholders and Management Information Circular March 22, 2018

    Notice of Annual and Special Meeting of Shareholders and Management Information Circular March 22, 2018

    Read PDF
  • loading
    Loading More...